Market Overview

UPDATE: Wellington Shields Upgrades Clorox Products to Buy on Favorable Outlook

Share:
Related CLX
Consumer Staples Like Nu Skin And P&G Get The Thumbs Up From Deutsche Bank
Deutsche Bank Likes Consumer Staples, Stock Market Bubble Or Not
Finding Some Of The Best-Quality Dividend Growth Stocks Using The Piotroski F Score (Seeking Alpha)

Wellington Shields upgraded Clorox Products (NYSE: CLX) from Hold to Buy and raised the price target to $95.00.

Wellington Shields analyst Leigh Ferst noted, "We have raised our outlook for CLX, moving the price target up to 95 and the rating back to a Buy. We believe that the top line momentum, improving margins and cash flow, and better market conditions, leave the company with room to beat expectations, improve its long term growth assumptions, and enjoy a higher valuation as a result. Using a FY14 EPS assumption of 4.75 and an estimated forward PE of 20 brings us a new price target of 95. Clorox seems to be charging ahead on all cylinders and we think the continuing positive business momentum should lead to higher valuation for the shares."

Clorox Products closed at $83.72 on Friday.

Latest Ratings for CLX

DateFirmActionFromTo
Jul 2016Deutsche BankMaintainsHold
Jun 2016Atlantic EquitiesInitiates Coverage onNeutral
May 2016JP MorganMaintainsUnderweight

View More Analyst Ratings for CLX
View the Latest Analyst Ratings

Posted-In: Wellington ShieldsAnalyst Color Upgrades Analyst Ratings

 

Related Articles (CLX)

View Comments and Join the Discussion!